𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interest in predictive testing for Parkinson's disease: Impact of neuroprotective therapy

✍ Scribed by N. Dahodwala; J. Connolly; J. Farmer; M.B. Stern; D. Jennings; A. Siderowf

Book ID
116820329
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
190 KB
Volume
13
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neuroprotective therapy in Parkinson's d
Neuroprotective therapy in Parkinson's disease and motor complications: A search for a pathogenesis-targeted, disease-modifying strategy
✍ C. Warren Olanow; Joseph Jankovic πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 1 views

The introduction of levodopa in the late 1960s represented a landmark in the therapy of Parkinson's disease (PD). However, motor complications of chronic levodopa therapy have emerged as a major limitation of this otherwise effective therapy. Advancing medical and surgical treatment of these complic

Psychosocial impact of predictive testin
Psychosocial impact of predictive testing for Huntington disease on support persons
✍ Williams, Janet K. ;Schutte, Debra L. ;Holkup, Patricia A. ;Evers, Catherine ;Mu πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 110 KB πŸ‘ 2 views

Although a support person is required by many centers during the predictive testing protocol for Huntington disease (HD), little is known about the psychosocial impact of predictive testing on persons serving in this role. Eighteen adults who were support persons during predictive HD testing in one